VBI Vaccines (VBV) News Today → Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad) Free VBV Stock Alerts Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVBIV Stock Earnings: VBI Vaccines Beats EPS, Misses Revenue for Q4 2023msn.com - April 16 at 2:06 PMVBI Vaccines Inc VBIVmorningstar.com - October 31 at 1:32 PMNo, Pfizer COVID-19 vaccine doesn't cause 'VAIDS.' That's not a real condition | Fact checkusatoday.com - September 26 at 10:38 AMUpdated COVID-19 vaccine recommended for everyone; old, young, immunocompromised will benefit mostusatoday.com - September 23 at 7:13 PMThe real data behind the new COVID vaccines the White House is pushingnypost.com - September 21 at 2:23 PMCOVID vaccine pill that kills virus before it infects the body could be comingnypost.com - September 15 at 8:44 PMBiden plans to ask Congress for funding to develop new COVID vaccine, may recommend shot for allfoxnews.com - August 30 at 9:59 PMVBI Vaccines slides on discounted stock and warrants offeringmsn.com - July 6 at 1:50 PMVBI Vaccines Shares Turn Lower, Erase After-Hours Gainsmarketwatch.com - July 5 at 7:19 PMVBI Vaccines gains ahead of upcoming presentation on hep B shotmsn.com - June 7 at 6:04 PMVBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Misses Revenue Estimatesmsn.com - May 15 at 11:57 AMRaymond James Maintains VBI Vaccines (VBIV) Outperform Recommendationmsn.com - April 14 at 6:42 PMVBI Vaccines to Cut Workforce by 30%-35%, Focus on Hepatitis B >VBIVmarketwatch.com - April 5 at 9:41 AMVBI Vaccines Shares Plumb New Depths on Restructuring Plans >VBIVmarketwatch.com - April 5 at 9:41 AMVBI Vaccines to focus on hep B treatments, conduct 1-for-30 reverse stock splitmsn.com - April 4 at 9:15 AMHow mRNA vaccines could target everything from cancer to the plaguenypost.com - March 30 at 6:07 PMModerna CEO grilled over plan to raise Covid vaccine price at Senate hearingnbcnews.com - March 28 at 8:20 AMPeople without insurance will still get free COVID vaccines once government's supply runs outusatoday.com - March 15 at 10:49 AMFlorida surgeon general’s Covid vaccine claims harm public, health agencies saytheguardian.com - March 14 at 7:37 PMLA County eases COVID vaccine, testing restrictions as emergency declarations endfoxnews.com - March 13 at 10:20 AMFlu vaccine was 68% effective at preventing hospitalization in children but less protective for seniors this seasoncnbc.com - February 24 at 8:57 PMDevelop vaccines for all animal influenza strain, says incoming WHO chief scientistreuters.com - February 22 at 9:34 PMPrior COVID infection provides just as much protection as vaccines, new study findsfoxnews.com - February 22 at 9:34 PMTwo Vaccines May Soon Shield Seniors Against RSVusnews.com - February 20 at 7:57 AMThe Rise of Virus-like Particles (VLPs) Vaccine Market Research 2023-2029: Opportunities and Challengesmarketwatch.com - February 15 at 9:59 AMAdvances and Growth Opportunities in RNA Vaccinesfinance.yahoo.com - February 11 at 7:11 PMFDA vaccine panel to consider annual COVID shots: What we knowusatoday.com - February 9 at 12:52 AMYearly COVID vaccine as proposed by FDA? 'Cart before the horse,' says doctorfoxnews.com - January 26 at 12:56 PMFDA proposes most Americans receive one annual COVID vaccine, similar to fluabcnews.go.com - January 25 at 9:37 AMU.S. FDA proposes shift to annual COVID vaccine shotsreuters.com - January 25 at 9:37 AMScientists Are Working on a COVID Vaccine You Can Drinkcnet.com - January 24 at 8:53 AMRSV vaccine: Moderna, Pfizer start a new FDA approval racecnbc.com - January 22 at 6:53 PMCDC investigating whether Pfizer COVID vaccine increases stroke risk for people over 65nypost.com - January 16 at 10:47 PMVaccine Market Latest Trends 2023, Drivers, and Projections Report from 2023-2029| 101 Pages Reportmarketwatch.com - January 14 at 8:27 PMModerna under fire for 400% price hike of COVID vaccine: ‘Outrageous’nypost.com - January 14 at 8:27 PMPentagon officially rescinds COVID-19 vaccine mandatecbsnews.com - January 13 at 6:12 PMPentagon ends COVID-19 vaccine mandate for US troopsnypost.com - January 13 at 6:12 PMVLP Vaccines Market Global and Regional Analysis and Forecast 2028marketwatch.com - January 10 at 10:01 AMLooking Into VBI Vaccines's Return On Capital Employedmsn.com - December 20 at 12:44 PMVBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Updatemarketwatch.com - November 10 at 8:59 PMFDA Approves Vaccine for Use During Third Trimester of Pregnancy to Prevent Whooping Cough in Infants Younger Than Two Months of Agefinance.yahoo.com - October 15 at 7:17 AMVBI Vaccines Secures $100 Million Debt Facility From K2 HealthVenturesfinance.yahoo.com - September 15 at 11:34 AMValneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri(R)barrons.com - September 8 at 5:47 PMValneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®tmcnet.com - September 8 at 2:45 AMVBI Vaccines stock slumps 10% on Q2 miss, net loss widens on forex impactseekingalpha.com - August 8 at 11:46 AMVBI Vaccines gets FDA orphan drug designation for brain cancer vaccine candidate VBI-1901seekingalpha.com - June 22 at 3:03 PMVBI Vaccines hepatitis B shot PreHevbri gets approval in UKseekingalpha.com - June 1 at 10:54 AMVBI Vaccines Inc. (VBV.TO)finance.yahoo.com - October 26 at 10:25 AM Get VBI Vaccines News Delivered to You Automatically Sign up to receive the latest news and ratings for VBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring… >>Click here to find out what it is. VBV Media Mentions By Week VBV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VBV News Sentiment▼-0.450.50▲Average News Sentiment VBV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VBV Articles This Week▼10▲VBV Articles Average Week Get VBI Vaccines News Delivered to You Automatically Sign up to receive the latest news and ratings for VBV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:VBV) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsThe Greatest Bull Market in Crypto History…Weiss RatingsNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VBI Vaccines Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.